-+ 0.00%
-+ 0.00%
-+ 0.00%

Mineralys CMO David Malcom Rodman sells USD 541,129 of common shares

PUBT·04/16/2026 01:45:59
Listen to the news
Mineralys CMO David Malcom Rodman sells USD 541,129 of common shares
  • Mineralys Therapeutics Chief Medical Officer David Malcom Rodman cut his stake to 69,792 shares following transactions on April 13-15.
  • Rodman acquired 14,058 shares via option exercises on April 13 at prices ranging from USD 1.08 to USD 14.25.
  • He sold 20,406 shares over April 13-15 at prices of USD 26.54 to USD 27.66.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001933414-26-000076), on April 15, 2026, and is solely responsible for the information contained therein.